This company listing is no longer active
Protalix BioTherapeutics Dividend
Dividend criteriumcontroles 0/6
Belangrijke informatie
n/a
Dividendrendement
n/a
Uitbetalingsratio
Gemiddelde opbrengst industrie | 1.1% |
Volgende betaaldatum dividend | n/a |
Ex-dividenddatum | n/a |
Dividend per aandeel | n/a |
Winst per aandeel | -₪0.26 |
Dividendrendementsvoorspelling | n/a |
Recente dividendupdates
Geen updates
Recent updates
Stabiliteit en groei van betalingen
Dividenden ophalen
Stabiel dividend: Insufficient data to determine if PLX's dividends per share have been stable in the past.
Groeiend dividend: Insufficient data to determine if PLX's dividend payments have been increasing.
Dividendrendement versus markt
Protalix BioTherapeutics Dividendrendement versus markt |
---|
Segment | Dividendrendement |
---|---|
Bedrijf (PLX) | n/a |
Markt onderkant 25% (IL) | 2.4% |
Markt Top 25% (IL) | 6.8% |
Gemiddelde industrie (Biotechs) | 1.1% |
Analist prognose (PLX) (tot 3 jaar) | n/a |
Opmerkelijk dividend: Unable to evaluate PLX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
Hoog dividend: Unable to evaluate PLX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Winstuitkering aan aandeelhouders
Verdiendekking: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Contante uitbetaling aan aandeelhouders
Kasstroomdekking: Unable to calculate sustainability of dividends as PLX has not reported any payouts.